Swiss National Bank’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Swiss National Bank’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-224,777	Closed	-$9.47M	–	2624
2023 Q2	$9.47M	Buy	224,777 +2,700	+1%	+$109K	0.01%	938
2023 Q1	$7.91M	Sell	222,077 -25,800	-10%	-$936K	0.01%	1008
2022 Q4	$9.09M	Buy	247,877 +4,600	+2%	+$182K	0.01%	972
2022 Q3	$11.5M	Sell	243,277 -2,000	-0.8%	-$129K	0.01%	816
2022 Q2	$17.6M	Hold	245,277	–	–	0.01%	666
2022 Q1	$19.9M	Buy	245,277 +17,600	+8%	+$1.49M	0.01%	686
2021 Q4	$23.4M	Sell	227,677 -1,600	-0.7%	-$154K	0.01%	652
2021 Q3	$20.1M	Buy	229,277 +400	+0.2%	+$36.2K	0.01%	682
2021 Q2	$20.5M	Buy	228,877 +86,400	+61%	+$7.3M	0.01%	692
2021 Q1	$10.8M	Buy	142,477 +800	+0.6%	+$60.3K	0.01%	961
2020 Q4	$9.65M	Hold	141,677	–	–	0.01%	955
2020 Q3	$7.53M	Buy	141,677 +2,100	+2%	+$125K	0.01%	943
2020 Q2	$8.13M	Buy	139,577 +18,800	+16%	+$1.01M	0.01%	874
2020 Q1	$4.76M	Buy	120,777 +1,900	+2%	+$111K	0.01%	963
2019 Q4	$7.07M	Buy	118,877 +1,800	+2%	+$96.8K	0.01%	944
2019 Q3	$6.23M	Buy	117,077 +1,900	+2%	+$97.5K	0.01%	972
2019 Q2	$5.88M	Buy	115,177 +2,300	+2%	+$107K	0.01%	1019
2019 Q1	$5.84M	Buy	112,877 +3,700	+3%	+$179K	0.01%	992
2018 Q4	$4.3M	Buy	109,177 +1,900	+2%	+$88.3K	0.01%	1074
2018 Q3	$5.53M	Buy	107,277 +7,400	+7%	+$362K	0.01%	1049
2018 Q2	$4.68M	Hold	99,877	–	–	0.01%	1151
2018 Q1	$3.55M	Buy	99,877 +4,600	+5%	+$180K	﹤0.01%	1268
2017 Q4	$4.15M	Hold	95,277	–	–	﹤0.01%	1172
2017 Q3	$4.98M	Buy	95,277 +5,400	+6%	+$301K	0.01%	1017
2017 Q2	$5.26M	Buy	89,877 +1,900	+2%	+$98.7K	0.01%	961
2017 Q1	$4.03M	Buy	87,977 +1,500	+2%	+$74.6K	0.01%	1109
2016 Q4	$4.55M	Hold	86,477	–	–	0.01%	1011
2016 Q3	$3.85M	Buy	86,477 +14,300	+20%	+$620K	0.01%	1075
2016 Q2	$2.75M	Buy	72,177 +16,369	+29%	+$719K	﹤0.01%	1279
2016 Q1	$2.22M	Buy	55,808 +12,900	+30%	+$532K	﹤0.01%	1382
2015 Q4	$2.08M	Buy	42,908 +8,800	+26%	+$391K	0.01%	1313
2015 Q3	$1.36M	Buy	34,108 +18,208	+115%	+$795K	﹤0.01%	1571
2015 Q2	$638K	Buy	+15,900	New	+$549K	﹤0.01%	2085

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Swiss National Bank's SYNH Position: Q3 2023 in Review

Swiss National Bank sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 224,777 shares — an estimated $9.47M sold.

Swiss National Bank first reported a position in SYNH in Q2 2015 and held it in 33 quarters. The position peaked at $23.4M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Swiss National Bank reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Swiss National Bank sold 224,777 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $9.47M.
Swiss National Bank first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 33 quarters.
Swiss National Bank's Syneos Health, Inc. Class A Common Stock position peaked at $23.4M in Q4 2021.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Swiss National Bank's 13F filing for Q3 2023, filed 8 Nov 2023.